@article{04d8a0184ac8483496b35af6d813b5f5,
title = "Old blood from heterochronic parabionts accelerates vascular aging in young mice: transcriptomic signature of pathologic smooth muscle remodeling",
abstract = "Vascular aging has a central role in the pathogenesis of cardiovascular diseases contributing to increased mortality of older adults. There is increasing evidence that, in addition to the documented role of cell-autonomous mechanisms of aging, cell-nonautonomous mechanisms also play a critical role in the regulation of vascular aging processes. Our recent transcriptomic studies (Kiss T. et al. Geroscience. 2020;42(2):727–748) demonstrated that circulating anti-geronic factors from young blood promote vascular rejuvenation in aged mice. The present study was designed to expand upon the results of this study by testing the hypothesis that circulating pro-geronic factors also contribute to the genesis of vascular aging phenotypes. To test this hypothesis, through heterochronic parabiosis, we determined the extent to which shifts in the vascular transcriptome (RNA-seq) are modulated by the old systemic environment. We reanalyzed existing RNA-seq data, comparing the transcriptome in the aorta arch samples isolated from isochronic parabiont aged (20-month-old) C57BL/6 mice [A–(A); parabiosis for 8 weeks] and young isochronic parabiont (6-month-old) mice [Y–(Y)] and also assessing transcriptomic changes in the aortic arch in young (6-month-old) parabiont mice [Y–(A); heterochronic parabiosis for 8 weeks] induced by the presence of old blood derived from aged (20-month-old) parabionts. We identified 528 concordant genes whose expression levels differed in the aged phenotype and were shifted towards the aged phenotype by the presence of old blood in young Y–(A) animals. Among them, the expression of 221 concordant genes was unaffected by the presence of young blood in A–(Y) mice. GO enrichment analysis suggests that old blood-regulated genes may contribute to pathologic vascular remodeling. IPA Upstream Regulator analysis (performed to identify upstream transcriptional regulators that may contribute to the observed transcriptomic changes) suggests that the mechanism of action of pro-geronic factors present in old blood may include inhibition of pathways mediated by SRF (serum response factor), insulin-like growth factor-1 (IGF-1) and VEGF-A. In conclusion, relatively short-term exposure to old blood can accelerate vascular aging processes. Our findings provide additional evidence supporting the significant plasticity of vascular aging and the existence of circulating pro-geronic factors mediating pathological remodeling of the vascular smooth muscle cells and the extracellular matrix.",
keywords = "Aging, Aneurysm, Aorta, Atherosclerosis, Heterochronic parabiosis, Transcriptome, Vascular aging",
author = "Tamas Kiss and {\'A}d{\'a}m Ny{\'u}l-T{\'o}th and Rafal Gulej and Stefano Tarantini and Tamas Csipo and Peter Mukli and Anna Ungvari and Priya Balasubramanian and Andriy Yabluchanskiy and Zoltan Benyo and Conley, {Shannon M.} and Wren, {Jonathan D.} and Lori Garman and Huffman, {Derek M.} and Anna Csiszar and Zoltan Ungvari",
note = "Funding Information: This work was supported by grants from the American Heart Association, the American Federation for Aging Research (DMH; Irene/Diamond Postdoctoral Transition Award to PB), the Oklahoma Center for the Advancement of Science and Technology, the National Institute on Aging (RF1AG072295, R01AG055395, R01AG068295; R01AG070915, K01AG073614), the National Institute of Neurological Disorders and Stroke (R01NS100782), the National Cancer Institute (R01CA255840), the Oklahoma Shared Clinical and Translational Resources (U54GM104938) with an Institutional Development Award (IDeA) from NIGMS, the Presbyterian Health Foundation, the Reynolds Foundation, the NIA-supported Geroscience Training Program in Oklahoma (T32AG052363), the Oklahoma Nathan Shock Center (P30AG050911), and the Cellular and Molecular GeroScience CoBRE (P20GM125528), the Einstein Nathan Shock Center (P30AG038072) and by the NKFIH (Nemzeti Kardiovaszkularis Laboratorium) and the TKP 2021. Analysis help was provided by the Oklahoma Medical Research Foundation Quantitative Analysis Core supported by COBRE grant 1 P30 GM110766-01 and the Oklahoma Shared Clinical and Translational Resources (U54GM104938) with an Institutional Development Award (IDeA) from NIGMS. The funding sources had no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the article for publication. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health, the American Heart Association, or the Presbyterian Health Foundation. Funding Information: This work was supported by grants from the American Heart Association, the American Federation for Aging Research (DMH; Irene/Diamond Postdoctoral Transition Award to PB), the Oklahoma Center for the Advancement of Science and Technology, the National Institute on Aging (RF1AG072295, R01AG055395, R01AG068295; R01AG070915, K01AG073614), the National Institute of Neurological Disorders and Stroke (R01NS100782), the National Cancer Institute (R01CA255840), the Oklahoma Shared Clinical and Translational Resources (U54GM104938) with an Institutional Development Award (IDeA) from NIGMS, the Presbyterian Health Foundation, the Reynolds Foundation, the NIA-supported Geroscience Training Program in Oklahoma (T32AG052363), the Oklahoma Nathan Shock Center (P30AG050911), and the Cellular and Molecular GeroScience CoBRE (P20GM125528), the Einstein Nathan Shock Center (P30AG038072) and by the NKFIH (Nemzeti Kardiovaszkularis Laboratorium) and the TKP 2021. Analysis help was provided by the Oklahoma Medical Research Foundation Quantitative Analysis Core supported by COBRE grant 1 P30 GM110766-01 and the Oklahoma Shared Clinical and Translational Resources (U54GM104938) with an Institutional Development Award (IDeA) from NIGMS. The funding sources had no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the article for publication. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health, the American Heart Association, or the Presbyterian Health Foundation. Publisher Copyright: {\textcopyright} 2022, The Author(s), under exclusive licence to American Aging Association.",
year = "2022",
month = apr,
doi = "10.1007/s11357-022-00519-1",
language = "English (US)",
volume = "44",
pages = "953--981",
journal = "GeroScience",
issn = "2509-2715",
publisher = "Springer International Publishing AG",
number = "2",
}